Skip to content

Our 2030 ambition

Then, our ambition for 2030 is to be:

An innovative and patient-driven company with a rich pipeline
A resilient, growing and highly profitable company balanced on three pillars: oncology and neuroscience & immuno-inflammation, cardiometabolism and venous disease, and Generics
A company with a measurable positive social impact
An attractive company, with proud and passionate employees

To reach this ambition, we rely on a strategy based on the following axes:

  • create a significant positive social impact for a sustainable world;
  • to be an innovative player in oncology, neuroscience and immuno-inflammation;
  • to be an ever-recognized leader in cardio metabolism and venous disease;
  • fuel organic profitable growth for our Generics;
  • perform with a reshaped industrial operations value chain;
  • be an agile organization and a digital performer;
  • be all proud and passionate about our Vocation.

Our Vocation

Committed to therapeutic progress to serve patient needs

Photo d'un m├ędecin avec son patient

Our Values

Servier's Values

Dare to innovate

Servier's Values

Care

Servier's Values

Grow by sharing

Servier's Values

Commit to succeed

Photo of a girl in consultation

Our Vision

Founded to serve health, our Group aspires to make a meaningful social impact for patients and for a sustainable world.